These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31430)

  • 1. Sustained release of sulphadiazine.
    Wise DL; McCormick GJ; Willet GP; Anderson LC; Howes JF
    J Pharm Pharmacol; 1978 Nov; 30(11):686-9. PubMed ID: 31430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained-release implants in the chemotherapy of experimental rodent malaria II. The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices.
    Judge BM; Howells RE; Graham NB; McNeill ME
    Ann Trop Med Parasitol; 1981 Oct; 75(5):511-9. PubMed ID: 7032431
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimalarials: screening of (orally administered) silver solfonamides against Plasmodium berghei.
    Wysor MS
    Chemotherapy; 1975; 21(5):284-8. PubMed ID: 1098869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on plasmodium berghei n. sp. Vincke and Lips, 1948. IV. The reaction of blood-induced P. berghei in albino mice to quinine and sulphadiazine.
    RAMAKRISHNAN SP; KRISHNASWAMI AK; SATYA PRAKASH
    Indian J Malariol; 1951 Sep; 5(3):455-64. PubMed ID: 14955279
    [No Abstract]   [Full Text] [Related]  

  • 5. Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
    Wysor MS
    Chemotherapy; 1975; 21(5):302-10. PubMed ID: 807459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria immunity and premunition in a Plasmodium berghei mouse model.
    Eling WM
    Isr J Med Sci; 1978 May; 14(5):542-53. PubMed ID: 355189
    [No Abstract]   [Full Text] [Related]  

  • 7. Oversaturation of urine with sulphadiazine during treatment with a small therapeutic dose.
    Ylitalo P; Vapaatalo H
    Arzneimittelforschung; 1977; 27(9):1726-8. PubMed ID: 579144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with sulphadiazine and pyrimethamine in the treatment of persons experimentally infected with chloroquine-resistant Plasmodium falciparum.
    Powell RD; DeGowin RL; McNamara JV
    Ann Trop Med Parasitol; 1967 Dec; 61(4):396-408. PubMed ID: 4947655
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on Plasmodium berghei Vincke and Lips, 1948. XXIX. The size of parasite population and its relation to the selection of a strain resistant to sulphadiazine.
    RAMAKRISHNAN SP; PRAKASH S; CHOWDHURY DS; BASU PC
    Indian J Malariol; 1961 Jun; 15():95-106. PubMed ID: 14490070
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of prior eradication of Plasmodium berghei infection on the foetal development and parasitaemic levels under the stress of pregnancy.
    Pathak G; Asnani PJ; Vinayak VK
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):139-46. PubMed ID: 2212635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in Plasmodium berghei following proguanil, sulphadiazine and mepacrine therapy.
    THURSTON JP
    Trans R Soc Trop Med Hyg; 1951 Jun; 44(6):703-6. PubMed ID: 14855618
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes.
    Beetsma AL; van de Wiel TJ; Sauerwein RW; Eling WM
    Exp Parasitol; 1998 Jan; 88(1):69-72. PubMed ID: 9501851
    [No Abstract]   [Full Text] [Related]  

  • 13. [On 2 types of effects of a metabolite, important for the causative agent, on the effectiveness of chemotherapeutic drugs. I. The influence of paraaminobenzoic acid on the effectiveness of sulfadiazine in infection caused by Plasmodium berghei berghei in mice].
    Kirakosian SD
    Med Parazitol (Mosk); 1969; 38(6):650-8. PubMed ID: 5373439
    [No Abstract]   [Full Text] [Related]  

  • 14. [New antimalarial sustained-release formulations based on bioresorbable polymers: therapeutic evaluation using the Plasmodium berghei model].
    Tsakala M; Gillet J; Gillard J
    J Pharm Belg; 1990; 45(1):5-11. PubMed ID: 2185357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acid.
    Wise DL; McCormick GJ; Willet GP; Anderson LC
    Life Sci; 1976 Sep; 19(6):867-73. PubMed ID: 787714
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemotherapeutic value of sulphadiazine in treatment of Acanthamoeba meningoencephalitis in mice.
    Rowan-Kelly B; Ferrante A; Thong YH
    Trans R Soc Trop Med Hyg; 1982; 76(5):636-8. PubMed ID: 7179416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and pharmacokinetics of sulphadiazine, N4-acetylsulphadiazine and trimethoprim following intravenous and intramuscular administration of a sulphadiazine/trimethoprim combination in sheep.
    Batzias GC; Delis GA; Koutsoviti-Papadopoulou M
    Vet Res Commun; 2005 Nov; 29(8):699-712. PubMed ID: 16369884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium berghei: characterization of antigens and their role in inducing immunity to infection.
    Grothaus GD; Packer BJ; Castilla MM; Muller MT; Kreier JP
    J Parasitol; 1984 Dec; 70(6):849-58. PubMed ID: 6396392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotherapy of rodent malaria. XVII. Dynamics of drug resistance. 3. Influence of drug combinations on the development of resistance to chloroquine in P. berghei.
    Peters W
    Ann Trop Med Parasitol; 1973 Jun; 67(2):143-54. PubMed ID: 4578935
    [No Abstract]   [Full Text] [Related]  

  • 20. Canine bordetellosis: chemotherapy using a sulphadiazine-trimethoprim combination.
    McCandlish IA; Thompson H
    Vet Rec; 1979 Jul; 105(3):51-4. PubMed ID: 555120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.